BIO-key International, Inc.

BIO-key International, Inc. Earnings Recaps

BKYI Industrials 2 recaps
Q1 2026 May 19, 2026

BIO-key's stock was unchanged following its Q1 2026 earnings release, reflecting a market verdict that results and guidance were broadly in line with expectations despite ongoing operational challenges.

Key takeaways
  • Revenues benefited from new customer wins and expanded deployments in defense and financial services markets.
  • Continued international expansion with regional partnerships in EMEA, India, and Vietnam supporting future growth prospects.
  • Partnership with TD Synnex’s DLT Solutions aims to simplify public sector procurement in the U.S., targeting zero trust and multifactor authentication mandates.
  • Business remains predominantly subscription-based with approximately 50% of new business sourced domestically via partners and 100% internationally through channel partners.
  • Company is optimistic on growth and financial position, with $7.6 million in book value including over $2 million in cash, while shares remain suspended from NASDAQ pending an appeal hearing in June.
Full recap
Q3 2025 Nov 15, 2025

BIO-key International reported third-quarter revenues of approximately $1.55 million, consistent with earlier quarters but reflecting a year-over-year decline due to timing variances in large customer orders. Strong renewal rates and upcoming customer contracts signal potential growth as operational enhancements are set for early 2026.

Key takeaways
  • Q3 revenues decreased by $600,000 year-over-year, primarily due to timing of large orders, with a strong outlook for fourth-quarter renewals.
  • The company anticipates contract renewal from a significant banking customer, potentially generating $1 million to $3 million early in 2026.
  • Strong customer retention rates exceed 90%, indicating robust demand for BIO-key’s solutions despite seasonal revenue fluctuations.
  • Upcoming product enhancements, including a major update to the PortalGuard identity platform and the new EcoID III fingerprint scanner, are expected to bolster market competitiveness.
  • BIO-key is poised to capitalize on increased defense spending, with ongoing deployments among major global defense agencies.
Full recap